CAPLIN POINT LAB LTD. (CAPLIPOINT) financials — quarterly results, P&L, cash flow, balance sheet, shareholding
Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin America, Africa, USA and other nations.[1]
Caplin Point Lab Ltd.
CAPLIPOINT
ROE21.1%
ROCE27.0%
Stock P/E50.4
Book Value₹270
Face Value₹2.00
High / Low₹2,689/1,500
Market Cap₹20,000Cr.
Current Price₹2,631
Dividend Yield0.23%
Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin America, Africa, USA and other nations.[1]
Quarterly Results
Yearly Results
Shareholding Pattern
Shareholding Trend
Balance Sheet
Cash Flows
Last updated at: 14 July 2026 at 10:49:06